Product
Anticonvulsant
1 clinical trial
5 indications
Indication
EpilepsyIndication
Malignant GliomaIndication
Seizure DisorderIndication
Grade 2 GliomaIndication
Grade 3 GliomaClinical trial
A Phase IV, Prospective, Open-Label, Parallel Study Evaluating the Effect of an Adjunctive Anti-Seizure Medication Using a Glutamatergic Modulator in Patients With Focal Epilepsy and High-Grade GliomaStatus: Terminated, Estimated PCD: 2023-04-30